Pros
There are genuinely wonderful people tucked away inside this organization. Most employees are kind, hardworking, and doing their best in an incredibly challenging environment. The compensation and medical benefits are competitive, and if you’re in urgent need of a paycheck, CSL will pay you reliably and on time. You’ll also gain exposure to global markets, different time zones, and cross-functional work. If you thrive on solving problems you didn’t create, putting out fires in systems you don’t own, and building stress resilience worthy of an Olympic medal, there’s no shortage of learning opportunities. To the company’s credit, many frontline employees care deeply about patients and show up with sincere intent every day.
Cons
If you’re considering a global role, start by Googling the recent layoffs, the disastrous August earnings release, the steep year-to-date stock decline, and the October Annual General Meeting (AGM), where shareholders delivered a rare second strike. CSL is in the middle of a massive restructuring, driven by serious financial headwinds, cost overruns, pipeline stagnation, and a crisis of investor confidence. Leadership has been reactive rather than strategic, and employees are caught in the fallout. Roles are shifting constantly. You might be hired for one remit, handed two more you didn’t ask for, and then reorganized out of the company within a year. The company is aiming to cut 15% of its workforce, but it’s likely to be more. Stability is hard to come by, and the promises made during recruiting tend to disappear faster than a hundred-dollar bill on a crowded city sidewalk. I wouldn’t put much stock in any promises from a CSL recruiter right now—they simply don’t have all the facts or the most up-to-date information. Global collaboration here doesn’t feel collaborative—it feels like sleep disruption. Expect regular 6am video calls with Europe and late-night sessions with Australia, often between 5pm and 10pm, squeezed between commutes to an office where almost none of your teammates are physically present. The return-to-office mandate was rolled out abruptly and used against employees who live more than an hour away. Commuting just to sit on Teams calls with colleagues on other continents isn’t collaboration—it’s theater, staged by a desperate CEO and Board President. And it’s the kind of theater that wrecks sleep, health, relationships, time with your kids, and any chance of exercise. Prepare for 55+ hour workweeks with no real downtime. If you’re hoping for a calm day at work, think again—this place keeps you running full speed, all the time. On top of that, the systems landscape is fragmented and outdated. You’ll spend more time troubleshooting broken processes and platform defects than actually adding value. CSL is drowning in unnecessary complexity—even the Board President admitted this to shareholders. When deadlines slip because of these issues, blame tends to flow downward, not upward. Morale is fractured. Burnout is everywhere. There’s been quiet talk around the watercooler about increased alcohol use among employees just trying to stay afloat. Some people look physically different within months—weight gain, stress etched into their faces, sheer exhaustion. Senior leaders are visibly strained. Even those tasked with shaping culture are barely keeping their heads above water. The KOP office is bleak and uninspiring. It feels more like a call center than a hub for knowledge or collaboration. Last updated circa 2013-14, it’s a cubicle farm with no modern upgrades for post-COVID collaboration. There’s a lingering fear that the return-to-office mandate could escalate to four or even five days a week. The CEO originally wanted five days, and with things spiraling, he could easily make that happen. Meanwhile, shareholder unrest at the AGM was loud enough to raise serious questions about the board and executive team. When a company loses nearly a significant portion of its market cap—$49 billion USD or 40% at the time this was written—executes sweeping layoffs, pushes out a CFO after earnings backlash (though they claimed she retired, which seems unlikely), and transparently tries to shed headcount to avoid severance costs, it’s time to pay attention. The churn speaks volumes. A global role here isn’t a career-building move—it’s a suicide mission. You’ll see CSL post roles frequently, but don’t mistake that for growth. What you’re seeing is turnover, playing out in real time.